Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/β-catenin Signaling Pathway.
Shichao WeiFeng JuJunshen XiaoJiaxue LiTing LiuZhaoyang HuPublished in: Cardiovascular drugs and therapy (2024)
These data support the cardioprotective effect of aloperine against myocardial I/R injury, which is mediated, at least in part, by the ERK1/2/β-catenin signaling pathway.